应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NLSP NLS Pharmaceutics Ltd.
交易中 12-15 11:29:02 EST
0.7620
+0.0000
0.00%
最高
0.7620
最低
0.7620
成交量
0.00
今开
0.7620
昨收
0.7620
日振幅
0.00%
总市值
324.00万
流通市值
260.45万
总股本
425.20万
成交额
0.00
换手率
0.00%
流通股本
341.80万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
NLS Pharmaceutics:在与Kadimastem合并后,合并公司将继续推进Itol-102项目
美股速递 · 10-29
NLS Pharmaceutics:在与Kadimastem合并后,合并公司将继续推进Itol-102项目
NLS Pharmaceutics Ltd. 宣布进行1比10的反向股票拆分并更改名称,以配合与Kadimastem的拟议合并
美股速递 · 10-29
NLS Pharmaceutics Ltd. 宣布进行1比10的反向股票拆分并更改名称,以配合与Kadimastem的拟议合并
NLS Pharmaceutics与Kadimastem宣布合并交易的重大前提条件已完成以及Kadimastem股票的退市日期
美股速递 · 10-29
NLS Pharmaceutics与Kadimastem宣布合并交易的重大前提条件已完成以及Kadimastem股票的退市日期
NLS Pharmaceutics与Kadimastem宣布Kadimastem与Targetgene之间的战略合作,以推动下一代基因编辑细胞疗法
美股速递 · 10-27
NLS Pharmaceutics与Kadimastem宣布Kadimastem与Targetgene之间的战略合作,以推动下一代基因编辑细胞疗法
Nls Pharmaceutics Ltd.盘中异动 股价大跌5.25%
市场透视 · 10-10
Nls Pharmaceutics Ltd.盘中异动 股价大跌5.25%
NLS Pharmaceutics Ltd.股东在特别股东大会上通过与Kadimastem的合并及相关提案
美股速递 · 09-30
NLS Pharmaceutics Ltd.股东在特别股东大会上通过与Kadimastem的合并及相关提案
Kadimastem与NLS Pharmaceutics Ltd.宣布拟议合并相关的SEC注册声明生效
美股速递 · 09-10
Kadimastem与NLS Pharmaceutics Ltd.宣布拟议合并相关的SEC注册声明生效
Nls Pharmaceutics Ltd.盘中异动 早盘股价大跌5.14%报2.03美元
市场透视 · 08-11
Nls Pharmaceutics Ltd.盘中异动 早盘股价大跌5.14%报2.03美元
Nls Pharmaceutics Ltd.盘中异动 急速拉升5.82%报2.00美元
市场透视 · 08-08
Nls Pharmaceutics Ltd.盘中异动 急速拉升5.82%报2.00美元
Nls Pharmaceutics Ltd.盘中异动 早盘股价大跌5.26%
市场透视 · 08-06
Nls Pharmaceutics Ltd.盘中异动 早盘股价大跌5.26%
Nls Pharmaceutics Ltd.盘中异动 早盘大幅拉升5.28%
市场透视 · 08-04
Nls Pharmaceutics Ltd.盘中异动 早盘大幅拉升5.28%
Nls Pharmaceutics Ltd.盘中异动 快速跳水5.47%
市场透视 · 08-01
Nls Pharmaceutics Ltd.盘中异动 快速跳水5.47%
Nls Pharmaceutics Ltd.盘中异动 股价大涨5.15%报2.04美元
市场透视 · 07-30
Nls Pharmaceutics Ltd.盘中异动 股价大涨5.15%报2.04美元
Nls Pharmaceutics Ltd.盘中异动 急速拉升5.16%
市场透视 · 07-16
Nls Pharmaceutics Ltd.盘中异动 急速拉升5.16%
Nls Pharmaceutics Ltd.盘中异动 早盘股价大跌5.80%
市场透视 · 07-11
Nls Pharmaceutics Ltd.盘中异动 早盘股价大跌5.80%
Nls Pharmaceutics Ltd.盘中异动 早盘急速下挫5.33%
市场透视 · 07-07
Nls Pharmaceutics Ltd.盘中异动 早盘急速下挫5.33%
Nls Pharmaceutics Ltd.盘中异动 股价大跌23.08%
市场透视 · 07-02
Nls Pharmaceutics Ltd.盘中异动 股价大跌23.08%
Nls Pharmaceutics Ltd.盘中异动 大幅跳水8.54%报2.55美元
市场透视 · 06-30
Nls Pharmaceutics Ltd.盘中异动 大幅跳水8.54%报2.55美元
Nls Pharmaceutics Ltd.盘中异动 急速上涨5.48%
市场透视 · 06-27
Nls Pharmaceutics Ltd.盘中异动 急速上涨5.48%
Nls Pharmaceutics Ltd.盘中异动 早盘快速下跌5.10%
市场透视 · 06-11
Nls Pharmaceutics Ltd.盘中异动 早盘快速下跌5.10%
暂无数据
公司概况
公司名称:
NLS Pharmaceutics Ltd.
所属市场:
NASDAQ
上市日期:
--
主营业务:
NLS Pharmaceutics Ltd.于2015年6月成立。 该公司是一家创新的生物制药公司,致力于发现和开发可改善罕见中枢神经系统疾病的改善生命的药物疗法。
发行价格:
--
{"stockData":{"symbol":"NLSP","market":"US","secType":"STK","nameCN":"NLS Pharmaceutics Ltd.","latestPrice":0.762,"timestamp":1765816142278,"preClose":0.762,"halted":8,"volume":0,"delay":0,"floatShares":3417970,"shares":4252000,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"12-15 11:29:02 EST","open":0.762,"high":0.762,"low":0.762,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"symbolChange":{"newSymbol":"NCEL","executeDate":"2025-10-31"},"adr":0,"listingDate":1611896400000,"exchange":"NASDAQ","adjPreClose":0.762,"volumeRatio":0},"requestUrl":"/m/hq/s/NLSP/tweets","defaultTab":"tweets","newsList":[{"id":"1166589130","title":"NLS Pharmaceutics:在与Kadimastem合并后,合并公司将继续推进Itol-102项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1166589130","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166589130?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:22","pubTimestamp":1761736977,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics:在与Kadimastem合并后,合并公司将继续推进Itol-102项目","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLSP","NCEL","BK4007"],"gpt_icon":0},{"id":"1171878787","title":"NLS Pharmaceutics Ltd. 宣布进行1比10的反向股票拆分并更改名称,以配合与Kadimastem的拟议合并","url":"https://stock-news.laohu8.com/highlight/detail?id=1171878787","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171878787?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:00","pubTimestamp":1761732022,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics Ltd. 宣布进行1比10的反向股票拆分并更改名称,以配合与Kadimastem的拟议合并。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLSP","BK4007","NCEL","NLSPW"],"gpt_icon":0},{"id":"1176769345","title":"NLS Pharmaceutics与Kadimastem宣布合并交易的重大前提条件已完成以及Kadimastem股票的退市日期","url":"https://stock-news.laohu8.com/highlight/detail?id=1176769345","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176769345?lang=zh_cn&edition=full","pubTime":"2025-10-29 15:54","pubTimestamp":1761724465,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics与Kadimastem宣布合并交易的重大前提条件已完成,并确认Kadimastem股票的退市日期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLSP","BK4007","NCEL"],"gpt_icon":0},{"id":"1131118792","title":"NLS Pharmaceutics与Kadimastem宣布Kadimastem与Targetgene之间的战略合作,以推动下一代基因编辑细胞疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1131118792","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131118792?lang=zh_cn&edition=full","pubTime":"2025-10-27 19:02","pubTimestamp":1761562934,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics与Kadimastem宣布Kadimastem与Targetgene之间的战略合作,以推动下一代基因编辑细胞疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCEL","BK4007","NLSPW","NLSP"],"gpt_icon":0},{"id":"2574045354","title":"Nls Pharmaceutics Ltd.盘中异动 股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574045354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574045354?lang=zh_cn&edition=full","pubTime":"2025-10-10 23:25","pubTimestamp":1760109905,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日23时25分,Nls Pharmaceutics Ltd.股票出现异动,股价大幅下挫5.25%。截至发稿,该股报1.77美元/股,成交量8.1056万股,换手率1.91%,振幅4.52%。Nls Pharmaceutics Ltd.股票所在的生物技术行业中,整体跌幅为0.75%。Nls Pharmaceutics Ltd.公司简介:NLS Pharmaceutics Ltd是一家临床阶段的生物制药公司,专注于为患有罕见和复杂中枢神经系统疾病且医疗需求未得到满足的患者发现和开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251010232506a4599c67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251010232506a4599c67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"1178969745","title":"NLS Pharmaceutics Ltd.股东在特别股东大会上通过与Kadimastem的合并及相关提案","url":"https://stock-news.laohu8.com/highlight/detail?id=1178969745","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178969745?lang=zh_cn&edition=full","pubTime":"2025-09-30 19:04","pubTimestamp":1759230284,"startTime":"0","endTime":"0","summary":"NLS Pharmaceutics Ltd.股东在特别股东大会上通过与Kadimastem的合并及相关提案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"1120879040","title":"Kadimastem与NLS Pharmaceutics Ltd.宣布拟议合并相关的SEC注册声明生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1120879040","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120879040?lang=zh_cn&edition=full","pubTime":"2025-09-10 18:00","pubTimestamp":1757498429,"startTime":"0","endTime":"0","summary":"Kadimastem与NLS Pharmaceutics Ltd.宣布拟议合并相关的SEC注册声明生效","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2558669878","title":"Nls Pharmaceutics Ltd.盘中异动 早盘股价大跌5.14%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558669878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558669878?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:47","pubTimestamp":1754920024,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时47分,Nls Pharmaceutics Ltd.股票出现波动,股价大幅跳水5.14%。截至发稿,该股报2.03美元/股,成交量6.1343万股,换手率1.25%,振幅6.91%。Nls Pharmaceutics Ltd.股票所在的生物技术行业中,整体涨幅为0.21%。Nls Pharmaceutics Ltd.公司简介:NLS Pharmaceutics Ltd是一家临床阶段的生物制药公司,专注于为患有罕见和复杂中枢神经系统疾病且医疗需求未得到满足的患者发现和开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811214704a6dfbeee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811214704a6dfbeee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2557598299","title":"Nls Pharmaceutics Ltd.盘中异动 急速拉升5.82%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557598299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557598299?lang=zh_cn&edition=full","pubTime":"2025-08-08 01:59","pubTimestamp":1754589591,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日01时59分,Nls Pharmaceutics Ltd.股票出现波动,股价急速上涨5.82%。截至发稿,该股报2.00美元/股,成交量7.0955万股,换手率1.45%,振幅5.91%。Nls Pharmaceutics Ltd.股票所在的生物技术行业中,整体跌幅为0.26%。Nls Pharmaceutics Ltd.公司简介:NLS Pharmaceutics Ltd是一家临床阶段的生物制药公司,专注于为患有罕见和复杂中枢神经系统疾病且医疗需求未得到满足的患者发现和开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808015951973a1550&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808015951973a1550&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2557308757","title":"Nls Pharmaceutics Ltd.盘中异动 早盘股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557308757","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557308757?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:45","pubTimestamp":1754487920,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日21时45分,Nls Pharmaceutics Ltd.股票出现波动,股价急速下跌5.26%。截至发稿,该股报1.80美元/股,成交量1.3353万股,换手率0.27%,振幅4.21%。Nls Pharmaceutics Ltd.股票所在的生物技术行业中,整体跌幅为0.28%。Nls Pharmaceutics Ltd.公司简介:NLS Pharmaceutics Ltd是一家临床阶段的生物制药公司,专注于为患有罕见和复杂中枢神经系统疾病且医疗需求未得到满足的患者发现和开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080621452094d38124&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080621452094d38124&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2556807503","title":"Nls Pharmaceutics Ltd.盘中异动 早盘大幅拉升5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556807503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556807503?lang=zh_cn&edition=full","pubTime":"2025-08-04 22:52","pubTimestamp":1754319151,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日22时52分,Nls Pharmaceutics Ltd.股票出现波动,股价大幅上涨5.28%。Nls Pharmaceutics Ltd.股票所在的生物技术行业中,整体涨幅为0.70%。Nls Pharmaceutics Ltd.公司简介:NLS Pharmaceutics Ltd是一家临床阶段的生物制药公司,专注于为患有罕见和复杂中枢神经系统疾病且医疗需求未得到满足的患者发现和开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080422523194cf0cd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080422523194cf0cd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2556830389","title":"Nls Pharmaceutics Ltd.盘中异动 快速跳水5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556830389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556830389?lang=zh_cn&edition=full","pubTime":"2025-08-01 01:37","pubTimestamp":1753983466,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日01时37分,Nls Pharmaceutics Ltd.股票出现波动,股价急速下跌5.47%。截至发稿,该股报1.90美元/股,成交量4.5109万股,换手率0.92%,振幅4.23%。Nls Pharmaceutics Ltd.股票所在的生物技术行业中,整体涨幅为2.48%。Nls Pharmaceutics Ltd.公司简介:NLS Pharmaceutics Ltd是一家临床阶段的生物制药公司,专注于为患有罕见和复杂中枢神经系统疾病且医疗需求未得到满足的患者发现和开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801013746972abf38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801013746972abf38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2555804772","title":"Nls Pharmaceutics Ltd.盘中异动 股价大涨5.15%报2.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555804772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555804772?lang=zh_cn&edition=full","pubTime":"2025-07-30 21:58","pubTimestamp":1753883896,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日21时58分,Nls Pharmaceutics Ltd.股票出现波动,股价急速拉升5.15%。截至发稿,该股报2.04美元/股,成交量2042股,换手率0.04%,振幅1.54%。Nls Pharmaceutics Ltd.股票所在的生物技术行业中,整体涨幅为0.40%。Nls Pharmaceutics Ltd.公司简介:NLS Pharmaceutics Ltd是一家临床阶段的生物制药公司,专注于为患有罕见和复杂中枢神经系统疾病且医疗需求未得到满足的患者发现和开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730215816a46bbe1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730215816a46bbe1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2551194684","title":"Nls Pharmaceutics Ltd.盘中异动 急速拉升5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551194684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551194684?lang=zh_cn&edition=full","pubTime":"2025-07-16 03:23","pubTimestamp":1752607414,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日03时23分,Nls Pharmaceutics Ltd.股票出现异动,股价快速上涨5.16%。截至发稿,该股报2.24美元/股,成交量11.3782万股,换手率2.32%,振幅5.16%。Nls Pharmaceutics Ltd.股票所在的生物技术行业中,整体跌幅为1.24%。Nls Pharmaceutics Ltd.公司简介:NLS Pharmaceutics Ltd是一家临床阶段的生物制药公司,专注于为患有罕见和复杂中枢神经系统疾病且医疗需求未得到满足的患者发现和开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507160323349543d70a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507160323349543d70a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2550957523","title":"Nls Pharmaceutics Ltd.盘中异动 早盘股价大跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550957523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550957523?lang=zh_cn&edition=full","pubTime":"2025-07-11 22:54","pubTimestamp":1752245697,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日22时54分,Nls Pharmaceutics Ltd.股票出现异动,股价大幅跳水5.80%。截至发稿,该股报2.11美元/股,成交量3.3255万股,换手率0.68%,振幅4.91%。Nls Pharmaceutics Ltd.股票所在的生物技术行业中,整体跌幅为0.98%。Nls Pharmaceutics Ltd.公司简介:NLS Pharmaceutics Ltd是一家临床阶段的生物制药公司,专注于为患有罕见和复杂中枢神经系统疾病且医疗需求未得到满足的患者发现和开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071122545797a2734f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071122545797a2734f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2549955563","title":"Nls Pharmaceutics Ltd.盘中异动 早盘急速下挫5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549955563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549955563?lang=zh_cn&edition=full","pubTime":"2025-07-07 22:41","pubTimestamp":1751899294,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日22时41分,Nls Pharmaceutics Ltd.股票出现异动,股价快速跳水5.33%。Nls Pharmaceutics Ltd.股票所在的生物技术行业中,整体跌幅为0.40%。Nls Pharmaceutics Ltd.公司简介:NLS Pharmaceutics Ltd是一家临床阶段的生物制药公司,专注于为患有罕见和复杂中枢神经系统疾病且医疗需求未得到满足的患者发现和开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707224134a43c1083&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707224134a43c1083&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NLSP","BK4007"],"gpt_icon":0},{"id":"2548890014","title":"Nls Pharmaceutics Ltd.盘中异动 股价大跌23.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548890014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548890014?lang=zh_cn&edition=full","pubTime":"2025-07-02 21:32","pubTimestamp":1751463122,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日21时32分,Nls Pharmaceutics Ltd.股票出现波动,股价快速下挫23.08%。截至发稿,该股报2.20美元/股,成交量11.4592万股,换手率2.33%,振幅6.56%。Nls Pharmaceutics Ltd.股票所在的生物技术行业中,整体跌幅为0.22%。Nls Pharmaceutics Ltd.公司简介:NLS Pharmaceutics Ltd是一家临床阶段的生物制药公司,专注于为患有罕见和复杂中枢神经系统疾病且医疗需求未得到满足的患者发现和开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702213202a4cb5383&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702213202a4cb5383&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2547090975","title":"Nls Pharmaceutics Ltd.盘中异动 大幅跳水8.54%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547090975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547090975?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:38","pubTimestamp":1751290711,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时38分,Nls Pharmaceutics Ltd.股票出现异动,股价急速跳水8.54%。截至发稿,该股报2.55美元/股,成交量25.0019万股,换手率5.09%,振幅7.89%。Nls Pharmaceutics Ltd.股票所在的生物技术行业中,整体涨幅为0.15%。Nls Pharmaceutics Ltd.公司简介:NLS Pharmaceutics Ltd是一家临床阶段的生物制药公司,专注于为患有罕见和复杂中枢神经系统疾病且医疗需求未得到满足的患者发现和开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213831a4c6c799&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213831a4c6c799&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2546307741","title":"Nls Pharmaceutics Ltd.盘中异动 急速上涨5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546307741","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546307741?lang=zh_cn&edition=full","pubTime":"2025-06-27 21:33","pubTimestamp":1751031183,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日21时33分,Nls Pharmaceutics Ltd.股票出现波动,股价急速拉升5.48%。Nls Pharmaceutics Ltd.股票所在的生物技术行业中,整体跌幅为0.30%。Nls Pharmaceutics Ltd.公司简介:NLS Pharmaceutics Ltd是一家临床阶段的生物制药公司,专注于为患有罕见和复杂中枢神经系统疾病且医疗需求未得到满足的患者发现和开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627213303a72104ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627213303a72104ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NLSP"],"gpt_icon":0},{"id":"2542753846","title":"Nls Pharmaceutics Ltd.盘中异动 早盘快速下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542753846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542753846?lang=zh_cn&edition=full","pubTime":"2025-06-11 21:51","pubTimestamp":1749649914,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日21时51分,Nls Pharmaceutics Ltd.股票出现异动,股价快速跳水5.10%。Nls Pharmaceutics Ltd.股票所在的生物技术行业中,整体涨幅为0.09%。Nls Pharmaceutics Ltd.公司简介:NLS Pharmaceutics Ltd是一家临床阶段的生物制药公司,专注于为患有罕见和复杂中枢神经系统疾病且医疗需求未得到满足的患者发现和开发创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611215154977b0af9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611215154977b0af9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NLSP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nlspharma.com","stockEarnings":[{"period":"1week","weight":-0.9},{"period":"1month","weight":-0.9},{"period":"3month","weight":-0.9646},{"period":"6month","weight":-0.9666},{"period":"1year","weight":-0.9611},{"period":"ytd","weight":-0.9639}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NLS Pharmaceutics Ltd.于2015年6月成立。 该公司是一家创新的生物制药公司,致力于发现和开发可改善罕见中枢神经系统疾病的改善生命的药物疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.055387},{"month":2,"riseRate":0.4,"avgChangeRate":-0.001667},{"month":3,"riseRate":0.6,"avgChangeRate":-0.007458},{"month":4,"riseRate":0,"avgChangeRate":-0.175846},{"month":5,"riseRate":0.4,"avgChangeRate":0.007372},{"month":6,"riseRate":0.6,"avgChangeRate":0.133578},{"month":7,"riseRate":0.2,"avgChangeRate":-0.210549},{"month":8,"riseRate":0.6,"avgChangeRate":0.043884},{"month":9,"riseRate":0.4,"avgChangeRate":-0.067099},{"month":10,"riseRate":0,"avgChangeRate":-0.243606},{"month":11,"riseRate":0.25,"avgChangeRate":0.023918},{"month":12,"riseRate":0.4,"avgChangeRate":-0.153973}],"exchange":"NASDAQ","name":"NLS Pharmaceutics Ltd.","nameEN":"NLS Pharmaceutics Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NLS Pharmaceutics Ltd.(NLSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NLS Pharmaceutics Ltd.(NLSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NLS Pharmaceutics Ltd.,NLSP,NLS Pharmaceutics Ltd.股票,NLS Pharmaceutics Ltd.股票老虎,NLS Pharmaceutics Ltd.股票老虎国际,NLS Pharmaceutics Ltd.行情,NLS Pharmaceutics Ltd.股票行情,NLS Pharmaceutics Ltd.股价,NLS Pharmaceutics Ltd.股市,NLS Pharmaceutics Ltd.股票价格,NLS Pharmaceutics Ltd.股票交易,NLS Pharmaceutics Ltd.股票购买,NLS Pharmaceutics Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NLS Pharmaceutics Ltd.(NLSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NLS Pharmaceutics Ltd.(NLSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}